Novel Immunogens For Influenza Virus Vaccines Read more about Novel Immunogens For Influenza Virus Vaccines Patent Cooperation TreatyPCT/US2023/060130Filed on 2023-01-05
METHODS OF MODELING IN VIVO EFFICACY OF DRUG COMBINATIONS FOR TREATMENT OF VIRAL INFECTIONS Read more about METHODS OF MODELING IN VIVO EFFICACY OF DRUG COMBINATIONS FOR TREATMENT OF VIRAL INFECTIONS Patent Cooperation TreatyPCT/US2022/015835Filed on 2022-02-09
Engineered Influenza Neuraminidase Antigens Read more about Engineered Influenza Neuraminidase Antigens Hong Kong62023069003.9Filed on 2023-02-25
COMPOSITION FOR PREVENTING OR TREATING SYSTEMIC CAPILLARY LEAK SYNDROME Read more about COMPOSITION FOR PREVENTING OR TREATING SYSTEMIC CAPILLARY LEAK SYNDROME South Korea10-2023-0027030Filed on 2023-02-28
NANOPARTICLE-DERIVED VACCINES AGAINST POXVIRUSES, AND METHODS FOR MAKING AND USING THE SAME Read more about NANOPARTICLE-DERIVED VACCINES AGAINST POXVIRUSES, AND METHODS FOR MAKING AND USING THE SAME Patent Cooperation TreatyPCT/US2023/031683Filed on 2023-08-31
Engineered Influenza Neuraminidase Antigens Read more about Engineered Influenza Neuraminidase Antigens US Application 17/904,157Filed on 2021-03-04
Engineered Influenza Neuraminidase Antigens Read more about Engineered Influenza Neuraminidase Antigens South Africa2022/09477Filed on 2021-03-04
Engineered Influenza Neuraminidase Antigens Read more about Engineered Influenza Neuraminidase Antigens Singapore11202252530HFiled on 2021-03-04
Engineered Influenza Neuraminidase Antigens Read more about Engineered Influenza Neuraminidase Antigens South Korea10-2022-7034599Filed on 2022-10-05
Engineered Influenza Neuraminidase Antigens Read more about Engineered Influenza Neuraminidase Antigens China202180019311.0Filed on 2021-03-04